Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREPARE: Vascepa for Colorectal Cancer Prevention
NCT04216251Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of omega-3-acid triglycerides in colorectal cancer (CRC), sponsored by Massachusetts General Hospital. Started Dec 2020; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04216251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04216251.